Home / Health / MJFF Funds 108 Grants for Parkinson's Cure
MJFF Funds 108 Grants for Parkinson's Cure
13 Oct
Summary
- MJFF awarded $62.4 million across 108 grants in two months.
- Funding targets experimental drugs, early detection tests, and brain scans.
- Previous grant round in 2025 funded 69 projects for $60.6 million.
The Michael J. Fox Foundation for Parkinson's Research has significantly boosted the global effort to combat Parkinson's disease. In a concentrated two-month period in late 2025, the foundation disbursed $62.4 million through 108 grants. This funding is strategically directed towards developing disease-modifying drugs and pioneering earlier detection methods.
The grants support a diverse range of research, including experimental therapies and the exploration of understudied biological targets. Initiatives like the 'Targets to Therapies' program aim to identify proteins and genes that could form the basis for new treatments. The 'Therapeutics Pipeline Program' also fuels the advancement of promising experimental drugs and technologies.
Earlier detection is another key focus, with new grants exploring biomarkers in blood, urine, and skin oil. Advanced brain imaging tools, such as next-generation MRI and PET scans, are also being funded to visualize the disease's progression in living patients. This comprehensive approach seeks to transform both research and patient care.
This recent funding round represents a substantial increase compared to the foundation's previous grant cycle in April and May 2025. That period saw 69 grants awarded totaling $60.6 million, highlighting a continuous and growing investment in Parkinson's research worldwide. The foundation's commitment reflects a broader mission to improve the lives of those affected by the condition.
